Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined ...

Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast ...

Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.

What Happened? Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 2.5% in the afternoon session after ...

Shares of Clover Health fell more than 8% on Thursday following a critical report from short seller Hindenburg Research claiming the company is under an active investigation by the Department of ...

Shares of Clover Health (CLOV) plunged ~20% on Wednesday following the company’s Q3 2025 results, as the health insurer sharply lowered its full-year guidance for adjusted EBITDA despite increasing ...

Clover Health also announced a significant increase in its Medicare Advantage membership. The membership rose to 153,000, marking a 53% increase during the Annual Enrollment Period. The company ...

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

Clover Health Investments, Corp. (CLOV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

Clover Health Investments, Corp. (CLOV) closed the most recent trading day at $4.09, moving -0.24% from the previous trading session. This change lagged the S&P 500's daily gain of 1.02%. Meanwhile, ...